isoxazoles has been researched along with Body Weight in 73 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (10.96) | 18.7374 |
| 1990's | 16 (21.92) | 18.2507 |
| 2000's | 18 (24.66) | 29.6817 |
| 2010's | 28 (38.36) | 24.3611 |
| 2020's | 3 (4.11) | 2.80 |
| Authors | Studies |
|---|---|
| Junior, RDM; Perdoncini, G; Soares, NM; Tucci, EC | 1 |
| Abd El Ghaffar, AE; Ali, DM; Eid, MM; Othman, AA; Sharaf, MS | 1 |
| Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y | 1 |
| Cowley, MA; Oldfield, BJ; Stefanidis, A; Watt, MJ | 1 |
| Beugnet, F; Fourie, J; Halos, L; Larsen, D; Lebon, W; Liebenberg, J | 1 |
| Ballon, JS; Contreras, I; Freyberg, R; Freyberg, Z; Leibel, RL; Lieberman, JA; Mayer, LE; Pajvani, UB; Rosenbaum, M | 1 |
| Demonte, LD; Lorenz, V; Luque, EH; Milesi, MM; Pacini, G; Repetti, MR; Varayoud, J | 1 |
| Boehm, GW; Chumley, MJ; Eimerbrink, MJ; Hayes, HB; Hodges, SL; Pendry, RJ; Peterman, JL; White, JD; Wiles, JD | 1 |
| Attané, C; Bertrand, C; Dusaulcy, R; Fournel, A; Grès, S; Prentki, M; Rancoule, C; Saulnier-Blache, JS; Tréguer, K; Valet, P; Vinel, C | 1 |
| Fan, B; Hu, J; Hu, S; Huang, M; Li, Y; Liao, Z; Peterson, BS; Tang, J; Wei, N; Xu, D; Xu, Y; Yao, M; Yuan, T; Yue, W; Zhou, W | 1 |
| Chen, B; Media, J; Shaw, J; Valeriote, F | 1 |
| Andrzejak, V; Barczyk, A; Body-Malapel, M; Chavatte, P; Desreumaux, P; Djouina, M; Leleu-Chavain, N; Millet, R; Rigo, B; Tourteau, A | 1 |
| Alphs, L; Bossie, CA; Fu, DJ; Sliwa, JK; Turkoz, I | 1 |
| Allan, MJ; Nuernberger, MC; Roepke, RK; Walther, FM | 2 |
| Eskandari, D; Grote, L; Hedner, J; Karimi, M; Stenlöf, K; Zou, D | 1 |
| Drag, M; Harriman, J; Larsen, D; Saik, J | 1 |
| Kumar, A; Mishra, J | 1 |
| Hou, YC; Lai, CH | 1 |
| Chen, X; Jin, J; Liu, D; Xue, N; Yan, R; Yu, X; Zhang, S | 1 |
| Chung, MK; Hwang, KH; Jeong, EJ; Koo, SJ; Lee, J; Song, J; Yu, WJ | 1 |
| Demeler, J; Heckeroth, AR; Roepke, RK; Taenzler, J; Williams, H; Zschiesche, E | 1 |
| He, T; Ji, Y; Lv, W; Wang, J; Zhang, Q | 1 |
| Baker, JF; Cannella, A; Cannon, GW; Caplan, L; Davis, L; Ibrahim, S; Jorgenson, E; Michaud, K; Mikuls, TR; Sauer, BC; Teng, CC | 1 |
| Beugnet, F; Crafford, D; de Vos, C; Fourie, J; Kok, D; Larsen, D | 1 |
| Anitha, M; Gao, X; Gonzalez, FJ; Jiang, C; Krausz, KW; Patterson, AD; Shi, J; Sun, D; Sun, L; Takahashi, S; Wang, T; Xie, C | 1 |
| Bansal, N; Bertino, JR; Birge, RB; Comollo, T; Kholodovych, V; Kimani, SG; Kotenko, SV; Kumar, S; Peng, Y; Sarafianos, SG; Singh, K; Welsh, WJ | 1 |
| Hashimoto, N; Higa, Y; Ishitsu, T; Nakagawa, K; Okada, Y; Seo, T; Wanibuchi, A | 1 |
| Aravagiri, M; Bies, RR; Coley, K; Feng, Y; Kirshner, M; Marder, S; Miller, D; Pollock, BG; Schneider, L | 1 |
| Bauer, J; Wellmer, J; Wellmer, S | 1 |
| Inokuma, S; Matsuda, T; Otsuka, T; Saeki, Y; Sagawa, A; Sato, T; Sawada, T; Takemura, T; Takeuchi, T | 1 |
| Eerdekens, M; Gassmann-Mayer, C; Gopal, S; Hough, D; Lim, P; Nasrallah, HA; Quiroz, JA; Yuen, E | 1 |
| Arita, E; Auwerx, J; Horai, Y; Houten, SM; Itoh, H; Mataki, C; Morimoto, K; Sato, H; Schoonjans, K; Sugizaki, T; Tanigawara, Y; Watanabe, M | 1 |
| Frøkiær, J; Jensen, BL; Madsen, K; Nilsson, L; Nørregaard, R; Topcu, SO | 1 |
| Aadamsoo, K; Bergmans, P; Fernández, LG; Hoeben, D; Korcsog, P; Niehaus, D; Salinas, R; Schreiner, A; Shuriquie, NA; Tessier, C; Theodoropoulou, P; Uçok, A | 1 |
| Bekersky, I; Bilolo, K; Chen, H; Daloze, P; Fitzsimmons, WE; Jiang, W; Johnson, S; Ma, A; Ouyang, J; Qi, S; Vu, MD; Wang, X; Xu, D; Zhu, S | 1 |
| Hudson, JI; Keck, PE; Kotwal, R; McElroy, SL; Nelson, EB | 1 |
| Li, Y; Qiang, CJ; Wei, YH | 1 |
| Chong, AS; Knight, DA; Ma, L; Meister, GT; Shen, J; Waldman, WJ; Williams, JW; Yin, DP; Zeng, H | 1 |
| Altshuler, LL; Black, D; Frye, MA; Grunze, H; Keck, PE; Kupka, RW; Leverich, GS; McElroy, SL; Nolen, WA; Post, RM; Suppes, T; Walden, J | 1 |
| Bhargava, VO; Kovacs, SJ; Ludden, TM; Shi, J; Wang, Y | 1 |
| Das, S; Dasgupta, A; Sarkar, PK | 1 |
| Davidson, M; Eerdekens, M; Emsley, R; Ford, L; Kramer, M; Lim, P; Pan, G | 1 |
| Bymaster, FP; Cowley, MA; Gadde, KM; Krishnan, RK; Landbloom, RP; McKinney, AA; Sinnayah, P; Tollefson, GD; Wallingford, NM | 1 |
| Achilleos, O; Antoniou, E; Buckels, J; Candinas, D; D'Silva, M; DeRoover, A; Germenis, A; Lee, S; Mayer, D; Stavropoulos, C | 1 |
| Daniels, DL; Debnath, ML; ElSourady, H; Hall, IH; Izydore, RA; Simlot, R; Wong, OT; Woodard, T | 1 |
| Gallagher, BC; Hanigan, MH; Large, MK; Taylor, PT | 1 |
| Amit, Z; Boyle, AE; Segal, R; Smith, BR | 1 |
| Chong, AS; Foster, P; Gebel, H; Guo, Z; Jensik, SC; McChesney, L; Mital, D; Sankary, HN; Shen, J; Williams, JW | 1 |
| Anai, M; Asano, T; Fukushima, Y; Funaki, M; Inukai, K; Ishihara, H; Katagiri, H; Kikuchi, M; Ogihara, T; Oka, Y; Onishi, Y; Sakoda, H; Shibata, T; Terasaki, J; Yazaki, Y | 1 |
| Berry, GJ; Boeke, K; Christians, U; Gummert, JF; Hausen, B; Morris, RE | 1 |
| Ko, DH; Lee, HJ | 1 |
| Matsui, K; Shibata, T; Wakitani, K; Yonemori, F | 1 |
| Kakimoto, K; Shibata, T; Takeuchi, S; Wakitani, K; Yokota, S; Yonemori, F | 1 |
| Beers, K; Bottje, WG; Cawthon, D; Song, Z | 1 |
| Achilleos, O; Candinas, D; D'Silva, M; Dalgic, A; Lee, SJ; Mayer, AD; McMaster, P; Miki, C | 1 |
| Hanigan, MH; Townsend, DM | 1 |
| Banerjee, BN; Ivins, NJ; Ludwig, BJ; Sofia, RD | 1 |
| DiPasquale, G; Rassaert, C; Tripp, L; Welaj, P | 1 |
| Adachi, T; Hirayama, K; Yasutake, A | 1 |
| Gotoh, K; Hayashi, S; Inazu, M; Inoue, T; Ogawa, T | 1 |
| Miyake, H; Ono, N; Sunami, A; Yamamoto, N; Yamasaki, Y | 1 |
| Ichiki, T; Kodama, R; Kuwasaki, E; Kuwata, M; Satoh, K; Sone, H; Yamamoto, N; Yamashita, K | 1 |
| Iwata, M; Kiguchi, M; Nasu, Y; Shimpo, K; Takeuchi, M; Yada, H; Yamashita, K | 1 |
| Armario, A; Garvey, JS; Hidalgo, J | 1 |
| Cao, L; Chance, WT; Fischer, JE; Foley-Nelson, T; Nelson, JL | 1 |
| Cao, L; Chance, WT; Fischer, JE | 1 |
| Barsoum, NJ; DiFonzo, CJ; Macallum, GE; Smith, GS; Walker, RM | 1 |
| Cao, L; Chance, WT; Fischer, JE; Kim, MW; Nelson, JL | 1 |
| Dahl, JE; Dybing, E; Nelson, SD; Omichinski, JG; Søderlund, EJ | 1 |
| Buchanan, RA; Friel, PN; Levy, RH; McLean, JR; Ojemann, LM; Shastri, RA; Wilensky, AJ | 1 |
1 review(s) available for isoxazoles and Body Weight
14 trial(s) available for isoxazoles and Body Weight
| Article | Year |
|---|---|
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Assessment of the insecticidal activity of afoxolaner against Aedes aegypti in dogs treated with NexGard
Topics: Administration, Oral; Aedes; Analysis of Variance; Animals; Body Weight; Dog Diseases; Dogs; Ectoparasitic Infestations; Female; Insect Vectors; Insecticides; Isoxazoles; Male; Naphthalenes | 2017 |
Pathophysiology of drug induced weight and metabolic effects: findings from an RCT in healthy volunteers treated with olanzapine, iloperidone, or placebo.
Topics: Adolescent; Adult; Antipsychotic Agents; Blood Glucose; Body Weight; Double-Blind Method; Dyslipidemias; Eating; Energy Metabolism; Female; Glucose Tolerance Test; Healthy Volunteers; Humans; Insulin; Insulin Resistance; Isoxazoles; Lipids; Male; Obesity; Olanzapine; Piperidines; Weight Gain; Young Adult | 2018 |
A randomized, 12-week study of the effects of extended-release paliperidone (paliperidone ER) and olanzapine on metabolic profile, weight, insulin resistance, and β-cell function in schizophrenic patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Weight; Delayed-Action Preparations; Female; Follow-Up Studies; Humans; Insulin Resistance; Insulin-Secreting Cells; Isoxazoles; Lipid Metabolism; Male; Olanzapine; Paliperidone Palmitate; Prospective Studies; Pyrimidines; Schizophrenia; Time Factors; Young Adult | 2013 |
Body mass index and metabolic parameters in patients with schizophrenia during long-term treatment with paliperidone palmitate.
Topics: Adult; Antipsychotic Agents; Blood Glucose; Body Mass Index; Body Weight; Double-Blind Method; Female; Humans; Isoxazoles; Lipids; Male; Middle Aged; Obesity; Paliperidone Palmitate; Palmitates; Schizophrenia; Weight Gain; Young Adult | 2014 |
The effect of food on the pharmacokinetics of oral fluralaner in dogs.
Topics: Acaricides; Administration, Oral; Animals; Antiparasitic Agents; Area Under Curve; Body Weight; Dogs; Dose-Response Relationship, Drug; Fasting; Female; Food; Food-Drug Interactions; Gastrointestinal Absorption; Insecticides; Isoxazoles; Male; Safety; Tablets | 2014 |
Safety of fluralaner chewable tablets (Bravecto), a novel systemic antiparasitic drug, in dogs after oral administration.
Topics: Acaricides; Administration, Oral; Animals; Antiparasitic Agents; Body Weight; C-Reactive Protein; Dogs; Dose-Response Relationship, Drug; Eating; Female; Hematology; Insecticides; Isoxazoles; Male; Organ Size; Safety; Single-Blind Method; Tablets; Time Factors | 2014 |
Zonisamide reduces obstructive sleep apnoea: a randomised placebo-controlled study.
Topics: Aged; Anthropometry; Body Mass Index; Body Weight; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Continuous Positive Airway Pressure; Double-Blind Method; Female; Humans; Isoxazoles; Male; Middle Aged; Patient Compliance; Placebos; Polysomnography; Sleep; Sleep Apnea, Obstructive; Weight Loss; Zonisamide | 2014 |
Evaluation of the efficacy of monthly oral administration of afoxolaner plus milbemycin oxime (NexGard Spectra(®), Merial) in the prevention of adult Spirocerca lupi establishment in experimentally infected dogs.
Topics: Administration, Oral; Analysis of Variance; Animals; Anthelmintics; Aorta, Thoracic; Autopsy; Body Weight; Dog Diseases; Dogs; Esophagoscopy; Esophagus; Feces; Female; Isoxazoles; Macrolides; Male; Naphthalenes; Parasite Egg Count; Spirurida Infections; Thelazioidea | 2016 |
A controlled, evidence-based trial of paliperidone palmitate, a long-acting injectable antipsychotic, in schizophrenia.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Body Mass Index; Body Weight; Case-Control Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Delivery Systems; Evidence-Based Medicine; Female; Humans; Injections; Isoxazoles; Kaplan-Meier Estimate; Male; Middle Aged; Paliperidone Palmitate; Palmitates; Psychiatric Status Rating Scales; Schizophrenia; Treatment Outcome | 2010 |
Metabolic effects of paliperidone extended release versus oral olanzapine in patients with schizophrenia: a prospective, randomized, controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body Weight; Delayed-Action Preparations; Female; Glucose Tolerance Test; Humans; Isoxazoles; Lipoproteins, HDL; Male; Metabolic Syndrome; Middle Aged; Olanzapine; Paliperidone Palmitate; Psychiatric Status Rating Scales; Pyrimidines; Schizophrenia; Triglycerides; Waist Circumference | 2012 |
Zonisamide in the treatment of binge-eating disorder: an open-label, prospective trial.
Topics: Administration, Oral; Adult; Anticonvulsants; Body Weight; Bulimia; Female; Humans; Isoxazoles; Male; Severity of Illness Index; Treatment Outcome; Zonisamide | 2004 |
Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial.
Topics: Adult; Ambulatory Care; Anticonvulsants; Bipolar Disorder; Body Mass Index; Body Weight; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Patient Dropouts; Prospective Studies; Psychiatric Status Rating Scales; Psychotropic Drugs; Severity of Illness Index; Treatment Outcome; Zonisamide | 2005 |
Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): results of a 6-week, randomized, placebo-controlled study.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Blood Glucose; Body Weight; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Dyskinesia, Drug-Induced; Female; Humans; Isoxazoles; Lipids; Male; Middle Aged; Neurologic Examination; Paliperidone Palmitate; Psychiatric Status Rating Scales; Pyrimidines; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2007 |
59 other study(ies) available for isoxazoles and Body Weight
| Article | Year |
|---|---|
Efficacy of fluralaner (Exzolt) for the treatment of natural Allopsoroptoides galli infestations in laying hens.
Topics: Animals; Body Weight; Chickens; Drinking Water; Female; Isoxazoles; Mite Infestations; Mites; Poultry Diseases | 2022 |
Evaluation of the scabicidal effect of a single dose of fluralaner in a rabbit model of crusted scabies.
Topics: Adult; Animals; Body Weight; Female; Humans; Isoxazoles; Ivermectin; Male; Rabbits; Sarcoptes scabiei; Scabies | 2023 |
Prevention of the adverse effects of olanzapine on lipid metabolism with the antiepileptic zonisamide.
Topics: Adiposity; Animals; Antioxidants; Antipsychotic Agents; Benzodiazepines; Body Weight; Drug Therapy, Combination; Eating; Female; Glucose; Homeostasis; Isoxazoles; Lipid Metabolism; Lipolysis; Motor Activity; Olanzapine; Oxygen Consumption; Random Allocation; Rats, Sprague-Dawley; Triglycerides; Zonisamide | 2017 |
Perinatal exposure to a glyphosate-based herbicide impairs female reproductive outcomes and induces second-generation adverse effects in Wistar rats.
Topics: Animals; Body Weight; Female; Fetal Growth Retardation; Glycine; Glyphosate; Herbicides; Isoxazoles; Lactation; Male; Placenta; Pregnancy; Pregnancy Rate; Prenatal Exposure Delayed Effects; Puberty; Rats, Wistar; Reproduction; Tetrazoles | 2018 |
The α5-GABA
Topics: Amyloid beta-Peptides; Animals; Body Weight; Brain-Derived Neurotrophic Factor; Cognition Disorders; Conditioning, Psychological; Fear; GABA Agonists; Gene Expression Regulation; Hippocampus; Isoxazoles; Lipopolysaccharides; Male; Membrane Glycoproteins; Memory; Mice; Mice, Inbred C57BL; Nuclear Receptor Subfamily 4, Group A, Member 2; Peptide Fragments; Protein-Tyrosine Kinases; RNA, Messenger; Triazines | 2019 |
Lysophosphatidic acid impairs glucose homeostasis and inhibits insulin secretion in high-fat diet obese mice.
Topics: Adipocytes; Animals; Body Weight; Diet, High-Fat; Gene Expression Regulation; Glucose; Glycogen; Homeostasis; Insulin; Insulin Secretion; Isoxazoles; Lipids; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Muscle, Skeletal; Oxygen; Propionates; Time Factors | 2013 |
The small-molecule TNF-α inhibitor, UTL-5g, delays deaths and increases survival rates for mice treated with high doses of cisplatin.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Body Weight; Cisplatin; Dose-Response Relationship, Drug; Female; Injections, Intraperitoneal; Isoxazoles; Maximum Tolerated Dose; Mice; Survival Rate; Time Factors; Tumor Necrosis Factor-alpha; Weight Loss | 2013 |
Switching cannabinoid response from CB(2) agonists to FAAH inhibitors.
Topics: Adamantane; Amidohydrolases; Animals; Anti-Inflammatory Agents; Body Weight; Cannabinoids; Colitis; Disease Models, Animal; Enzyme Inhibitors; Isoxazoles; Male; Mice; Mice, Inbred C57BL; Protein Binding; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2014 |
Safety evaluation of orally administered afoxolaner in 8-week-old dogs.
Topics: Administration, Oral; Animals; Antiparasitic Agents; Body Weight; Dogs; Female; Isoxazoles; Male; Naphthalenes; Random Allocation; Safety | 2014 |
Improvement of mitochondrial function by paliperidone attenuates quinolinic acid-induced behavioural and neurochemical alterations in rats: implications in Huntington's disease.
Topics: Acetylcholinesterase; Animals; Biogenic Amines; Body Weight; Corpus Striatum; Huntington Disease; Isoxazoles; Male; Maze Learning; Memory Disorders; Mitochondria; Movement Disorders; Neurons; Neuroprotective Agents; Oxidative Stress; Oxygen; Paliperidone Palmitate; Pyrimidines; Quinolinic Acid; Rats, Wistar | 2014 |
Lower risk for body weight gain and better control of appetite after switching risperidone to paliperidone in a schizoaffective patient.
Topics: Adult; Antipsychotic Agents; Appetite; Body Weight; Female; Humans; Isoxazoles; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone | 2014 |
Antiproliferative effect of HSP90 inhibitor Y306zh against pancreatic cancer is mediated by interruption of AKT and MAPK signaling pathways.
Topics: Animals; Antineoplastic Agents; Body Weight; Cell Line; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drugs, Investigational; G2 Phase; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Male; MAP Kinase Signaling System; Mice, Nude; Molecular Targeted Therapy; Neoplasm Proteins; Pancreatic Neoplasms; Proto-Oncogene Proteins c-akt; Pyridones; Random Allocation; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
Developmental toxicity assessment of the new turf herbicide, methiozolin ([5-(2,6-difluorobenzyl)oxymethyl-5-methyl-3,3(3-methylthiophen-2-yl)-1,2-isoxazoline]), in rabbits.
Topics: Animals; Body Weight; Female; Herbicides; Isoxazoles; Male; No-Observed-Adverse-Effect Level; Pregnancy; Pregnancy Outcome; Rabbits; Thiophenes; Weight Gain | 2015 |
A quantitative evaluation of the extent of fluralaner uptake by ticks (Ixodes ricinus, Ixodes scapularis) in fluralaner (Bravecto) treated vs. untreated dogs using the parameters tick weight and coxal index.
Topics: Acaricides; Animals; Body Weight; Dog Diseases; Dogs; Drug Evaluation; Female; Isoxazoles; Ixodes; Male; Tick Infestations | 2015 |
Protective effects of leflunomide on renal lesions in a rat model if diabetic nephropathy.
Topics: Actins; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Blood Urea Nitrogen; Body Weight; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Evaluation, Preclinical; Immunosuppressive Agents; Isoxazoles; Kidney; Leflunomide; Male; Organ Size; Osteopontin; Rats, Wistar; Transforming Growth Factor beta1 | 2016 |
Changes in Body Mass Related to the Initiation of Disease-Modifying Therapies in Rheumatoid Arthritis.
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Body Mass Index; Body Weight; Female; Humans; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Prednisone; Tumor Necrosis Factor-alpha | 2016 |
An Intestinal Farnesoid X Receptor-Ceramide Signaling Axis Modulates Hepatic Gluconeogenesis in Mice.
Topics: Acetyl Coenzyme A; Amidohydrolases; Animals; Body Weight; Caffeic Acids; Ceramides; Diet, High-Fat; Gastrointestinal Microbiome; Gluconeogenesis; Ileum; Insulin; Intestinal Mucosa; Intestines; Isoxazoles; Liver; Male; Mice; Mice, Inbred C57BL; Mitochondria, Liver; Phenylethyl Alcohol; Pyruvate Carboxylase; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Taurocholic Acid | 2017 |
Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicity.
Topics: Animals; Axl Receptor Tyrosine Kinase; Binding Sites; Body Weight; c-Mer Tyrosine Kinase; Carcinogenesis; Cell Line, Tumor; Humans; Intercellular Signaling Peptides and Proteins; Isoxazoles; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasms; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Transplantation, Heterologous | 2017 |
Population estimation regarding the effects of cytochrome P450 2C19 and 3A5 polymorphisms on zonisamide clearance.
Topics: Adolescent; Adult; Algorithms; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Body Weight; Child; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Drug Interactions; Female; Humans; Isoxazoles; Japan; Male; Models, Statistical; Polymorphism, Genetic; Population; Sex Characteristics; Young Adult; Zonisamide | 2008 |
Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements from the CATIE study.
Topics: Adult; Age Factors; Aged; Alzheimer Disease; Antipsychotic Agents; Biological Availability; Body Weight; Female; Humans; Isoxazoles; Male; Metabolic Clearance Rate; Middle Aged; Models, Chemical; Models, Statistical; Paliperidone Palmitate; Pyrimidines; Randomized Controlled Trials as Topic; Risperidone; Sample Size; Sampling Studies; Schizophrenia | 2008 |
The impact of zonisamide on weight. A clinical study in 103 patients with epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Body Mass Index; Body Weight; Dose-Response Relationship, Drug; Drug Interactions; Epilepsy; Female; Follow-Up Studies; Humans; Isoxazoles; Male; Middle Aged; Retrospective Studies; Time Factors; Young Adult; Zonisamide | 2009 |
Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Body Weight; Female; Humans; Isoxazoles; Japan; Leflunomide; Lung Diseases, Interstitial; Male; Middle Aged; Prevalence; Product Surveillance, Postmarketing; Risk Factors; Smoking | 2009 |
Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure.
Topics: 3T3-L1 Cells; Animals; Bile Acids and Salts; Body Weight; Diabetes Mellitus; Dietary Fats; Energy Metabolism; Isoxazoles; Metabolic Syndrome; Mice; Obesity; Receptors, Cytoplasmic and Nuclear | 2011 |
Disruption of cyclooxygenase-2 prevents downregulation of cortical AQP2 and AQP3 in response to bilateral ureteral obstruction in the mouse.
Topics: Animals; Aquaporin 2; Aquaporin 3; Blotting, Western; Body Weight; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Down-Regulation; Electrophoresis, Polyacrylamide Gel; Immunohistochemistry; Isoxazoles; Kidney; Kidney Cortex; Mice; Mice, Inbred C57BL; Mice, Knockout; Organ Size; Polymerase Chain Reaction; RNA; Ureteral Obstruction | 2012 |
Significant prolongation of renal allograft survival by delayed combination therapy of FK778 with tacrolimus in nonhuman primates.
Topics: Alanine Transaminase; Alkynes; Animals; Aspartate Aminotransferases; Body Weight; Chlorocebus aethiops; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Graft Survival; Immunosuppressive Agents; Isoxazoles; Kidney; Kidney Transplantation; Liver; Male; Nitriles; Tacrolimus; Time Factors | 2003 |
Effects and mechanisms of FR167653, a dual inhibitor of interleukin-1 and tumor necrosis factor, on adjuvant arthritis in rats.
Topics: Animals; Arthritis, Experimental; Body Weight; Cell Proliferation; China; Disease Models, Animal; Down-Regulation; Freund's Adjuvant; Injections, Subcutaneous; Interleukin-1; Interleukin-10; Isoxazoles; Knee Joint; Leflunomide; Male; Organ Size; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Spleen; Synovial Fluid; Thymus Gland; Tumor Necrosis Factor-alpha | 2004 |
Mechanistic study of malononitrileamide FK778 in cardiac transplantation and CMV infection in rats.
Topics: Alkynes; Animals; Antiviral Agents; Body Weight; Cytomegalovirus Infections; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Nitriles; Rats; Rats, Inbred BN; Transplantation, Homologous; Uridine; Virus Replication | 2005 |
[Effective and 15 years experience. New add-on option in epilepsy therapy]].
Topics: Anticonvulsants; Body Weight; Child; Controlled Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Approval; Drug Interactions; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; Humans; Isoxazoles; Patient Acceptance of Health Care; Zonisamide | 2005 |
[Control of side effects. Add on therapy demonstrates good tolerance].
Topics: Anticonvulsants; Body Weight; Controlled Clinical Trials as Topic; Drug Interactions; Drug Therapy, Combination; Epilepsy; Humans; Isoxazoles; Patient Acceptance of Health Care; Treatment Outcome; Zonisamide | 2005 |
Population pharmacokinetics of the active metabolite of leflunomide in pediatric subjects with polyarticular course juvenile rheumatoid arthritis.
Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Body Weight; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Isoxazoles; Leflunomide; Male; Models, Biological; Monte Carlo Method; Randomized Controlled Trials as Topic | 2005 |
Thyroid hormone stimulates gamma-glutamyl transpeptidase in the developing rat cerebra and in astroglial cultures.
Topics: Age Factors; Animals; Animals, Newborn; Antithyroid Agents; Astrocytes; Body Weight; Cell Survival; Cerebral Cortex; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Female; gamma-Glutamyltransferase; Glutathione; Hypothyroidism; Immunohistochemistry; Isoxazoles; Male; Pregnancy; Radioimmunoassay; Rats; Thiouracil; Thyroid Hormones; Time Factors | 2005 |
Zonisamide prevents olanzapine-associated hyperphagia, weight gain, and elevated blood glucose in rats.
Topics: Animals; Anticonvulsants; Appetite Regulation; Benzodiazepines; Biomarkers; Body Weight; Diabetes Mellitus; Female; Hyperglycemia; Hyperphagia; Hypothalamic Area, Lateral; Intracellular Signaling Peptides and Proteins; Isoxazoles; Neurons; Neuropeptides; Nucleus Accumbens; Obesity; Olanzapine; Orexins; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Weight Gain; Zonisamide | 2008 |
The immunomodulatory effect of leflunomide in rat cardiac allotransplantation.
Topics: Animals; Blood Urea Nitrogen; Body Weight; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Rats; Rats, Inbred Lew; Transplantation, Homologous | 1995 |
Investigation of 3,5-isoxazolidinediones as hypolipidemic agents in rodents.
Topics: Animals; Body Weight; Cholesterol; Hyperlipidemias; Hypolipidemic Agents; Isoxazoles; Lipoproteins; Male; Mice; Mice, Inbred Strains; Organ Size; Rats; Rats, Sprague-Dawley; Triglycerides | 1995 |
Inhibition of gamma-glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin-induced toxicity.
Topics: Animals; Blood Urea Nitrogen; Body Weight; Cisplatin; Creatinine; Eating; gamma-Glutamyltransferase; Glutathione; Isoxazoles; Kidney; Kidney Tubules, Proximal; Male; Rats; Rats, Sprague-Dawley | 1994 |
Bidirectional effects of GABAergic agonists and antagonists on maintenance of voluntary ethanol intake in rats.
Topics: Alcohol Drinking; Animals; Appetite Depressants; Body Weight; Chloride Channels; GABA-A Receptor Antagonists; Isoxazoles; Male; Picrotoxin; Rats; Receptors, GABA-A; Self Administration | 1993 |
In vivo effects of leflunomide on normal pancreatic islet and syngeneic islet graft function.
Topics: Animals; Body Weight; Cyclosporine; Immunosuppressive Agents; Islets of Langerhans; Islets of Langerhans Transplantation; Isoxazoles; Leflunomide; Rats; Tacrolimus; Time Factors | 1997 |
Role of JTT-501, a new insulin sensitiser, in restoring impaired GLUT4 translocation in adipocytes of rats fed a high fat diet.
Topics: Adipocytes; Animals; Blood Glucose; Body Weight; Cell Membrane; Cells, Cultured; Dietary Fats; Glucose Clamp Technique; Glucose Transporter Type 4; Humans; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Isoxazoles; Kinetics; Male; Monosaccharide Transport Proteins; Muscle Proteins; Rats; Rats, Sprague-Dawley; Recombinant Proteins | 1998 |
Potentiation of immunosuppressive efficacy by combining the novel leflunomide analog, HMR 279, with microemulsion cyclosporine in a rat lung transplant model.
Topics: Amides; Aniline Compounds; Animals; Biotransformation; Body Weight; Chromatography, High Pressure Liquid; Crotonates; Cyclosporine; Drug Therapy, Combination; Emulsions; Hydroxybutyrates; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lung Transplantation; Male; Nitriles; Rats; Rats, Inbred BN; Rats, Inbred Lew; Structure-Activity Relationship; Toluidines | 1999 |
A novel approach to the discovery of non-systemic anti-inflammatory steroids; antedrug.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Body Weight; Carboxylic Acids; Corticosterone; Croton Oil; Drug Evaluation; Ear Diseases; Edema; Isoxazoles; Male; Organ Size; Prednisolone; Prodrugs; Protein Binding; Rats; Rats, Sprague-Dawley | 1999 |
Triglyceride-lowering effect of a novel insulin-sensitizing agent, JTT-501.
Topics: Animals; Blood Glucose; Body Weight; Dietary Fats; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Insulin Resistance; Isoxazoles; Male; Pioglitazone; Rats; Rats, Sprague-Dawley; Thiazoles; Thiazolidinediones; Triglycerides | 1999 |
Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats.
Topics: Absorptiometry, Photon; Animals; Body Weight; Bone Density; Bone Diseases, Metabolic; Cataract; Chromans; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Neuropathies; Eating; Hypoglycemic Agents; Isoxazoles; Male; Neural Conduction; Obesity; Pancreas; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Troglitazone | 2000 |
Biliary glutathione secretion in male single comb white leghorn chickens after inhibition of gamma-glutamyl transpeptidase.
Topics: Animals; Bile; Bile Ducts; Body Weight; Chickens; Constriction; Enzyme Inhibitors; gamma-Glutamyltransferase; Glutathione; Isoxazoles; Liver; Male; Oxidation-Reduction | 2000 |
The immunomodulatory effects of a novel agent, leflunomide, in rat cardiac allotransplantation.
Topics: Animals; Body Weight; Cyclosporine; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Tacrolimus; Time Factors; Transplantation, Homologous | 1994 |
Inhibition of gamma-glutamyl transpeptidase or cysteine S-conjugate beta-lyase activity blocks the nephrotoxicity of cisplatin in mice.
Topics: Aminooxyacetic Acid; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Blood Urea Nitrogen; Body Weight; Carbon-Sulfur Lyases; Cisplatin; Enzyme Inhibitors; gamma-Glutamyltransferase; Isoxazoles; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Platinum; Survival Analysis | 2002 |
Toxicological investigation of 2,3-dihydro-9H-isoxazolo[3,2-b]quinazolin-9-one (W-2429). Acute and subacute toxicity in mice, rats and dogs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Cell Count; Blood Chemical Analysis; Body Weight; Dogs; Female; Isoxazoles; Lethal Dose 50; Male; Mice; Organ Size; Oxazoles; Quinazolines; Rats; Spermatogenesis; Time Factors | 1977 |
Anti-inflammatory activity of isoxicam in combination with aspirin or D-propoxyphene.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Aspirin; Body Weight; Dextropropoxyphene; Drug Therapy, Combination; Isoxazoles; Male; Organ Size; Oxazoles; Piroxicam; Rats; Thiazines | 1976 |
Influence of dietary protein levels on the fate of methylmercury and glutathione metabolism in mice.
Topics: Animals; Body Weight; Dietary Proteins; Guanosine Triphosphate; Half-Life; Isoxazoles; Kidney; Liver; Male; Methylmercury Compounds; Mice; Mice, Inbred C57BL; Organ Size; Tissue Distribution | 1992 |
Therapeutic effects of leflunomide, a new antirheumatic drug, on glomerulonephritis induced by the antibasement membrane antibody in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Anti-Idiotypic; Azathioprine; Basement Membrane; Body Weight; Cholesterol; Fibrinogen; Glomerulonephritis; Immunoglobulin G; Immunosuppressive Agents; Isoxazoles; Kidney Glomerulus; Leflunomide; Male; Methylprednisolone; Methylprednisolone Acetate; Proteinuria; Rabbits; Rats; Rats, Inbred Strains | 1991 |
[Pharmacological profile of mofezolac, a new non-steroidal analgesic anti-inflammatory drug].
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Body Weight; Capillary Permeability; Cyclooxygenase Inhibitors; Edema; Gastric Mucosa; Isoxazoles; Mice; Organ Size; Oxazoles; Platelet Aggregation Inhibitors; Rabbits; Rats | 1990 |
Acute toxicity tests of mofezolac (N-22) in mice and rats.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Female; Gastrointestinal Diseases; Injections, Intraperitoneal; Injections, Subcutaneous; Isoxazoles; Lethal Dose 50; Male; Mice; Mice, Inbred ICR; Rats; Rats, Inbred Strains | 1990 |
[Three-month subacute oral toxicity study of mofezolac (N-22) in dogs].
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Proteins; Body Weight; Dogs; Duodenal Ulcer; Erythrocyte Count; Female; Isoxazoles; Male; Organ Size; Stomach Ulcer | 1990 |
On the metallothionein, glutathione and cysteine relationship in rat liver.
Topics: Animals; Body Weight; Buthionine Sulfoximine; Cysteine; Glutathione; Isoxazoles; Liver; Male; Metallothionein; Methionine Sulfoximine; Organ Size; Rats; Rats, Inbred Strains; Starvation; Stress, Physiological; Zinc | 1990 |
Acivicin reduces tumor growth during total parenteral nutrition (TPN).
Topics: Animals; Antimetabolites; Body Weight; Glutamine; Isoxazoles; Male; Neoplasm Transplantation; Oxazoles; Parenteral Nutrition, Total; Rats; Rats, Inbred F344; Sarcoma, Experimental; Soft Tissue Neoplasms | 1987 |
Insulin and acivicin improve host nutrition and prevent tumor growth during total parenteral nutrition.
Topics: Animals; Antimetabolites; Body Weight; Eating; Energy Intake; Insulin; Isoxazoles; Male; Muscle Proteins; Muscles; Organ Size; Oxazoles; Parenteral Nutrition, Total; Rats; Rats, Inbred F344; Sarcoma, Experimental | 1988 |
Chronic toxicity of the anticonvulsant zonisamide in beagle dogs.
Topics: Administration, Oral; Animals; Anticonvulsants; Body Weight; Dogs; Eating; Electrocardiography; Isoxazoles; Liver; Oxazoles; Serum Albumin; Sex Factors; Time Factors; Zonisamide | 1988 |
Reduction of tumor growth following treatment with a glutamine antimetabolite.
Topics: Amino Acids; Animals; Antibiotics, Antineoplastic; Antimetabolites; Body Weight; Energy Intake; Glutamine; Isoxazoles; Male; Methylcholanthrene; Oxazoles; Rats; Rats, Inbred F344; Sarcoma, Experimental | 1988 |
Nephrotoxicity of selectively deuterated and methylated analogues of Tris-BP and Bis-BP in the rat.
Topics: Animals; Blood Urea Nitrogen; Body Weight; Creatinine; Gas Chromatography-Mass Spectrometry; Glutathione; Isoxazoles; Kidney Diseases; Male; Methylation; Necrosis; Organ Size; Organophosphates; Organophosphorus Compounds; Probenecid; Rats; Rats, Inbred Strains | 1988 |
Comparative pharmacokinetics of zonisamide (CI-912) in epileptic patients on carbamazepine or phenytoin monotherapy.
Topics: Adolescent; Adult; Anticonvulsants; Body Weight; Carbamazepine; Drug Therapy, Combination; Epilepsy; Erythrocytes; Female; Humans; Isoxazoles; Kinetics; Male; Oxazoles; Phenytoin; Zonisamide | 1986 |